Public-registry site landscape for NCT07736937, a Ovarian Cancer study sponsored by Tubulis GmbH. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07736937 (registry record) |
| Sponsor | Tubulis GmbH |
| Condition(s) | Ovarian Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 5 |
| Site countries | Belgium, Ukraine |
At UCL Louvain — one of the facilities listed on this trial — 6 other studies are actively recruiting Ovarian Cancer patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07736937 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →